PDCD1 and neoplasm: The crucial role of PD-1/PD-L1 interaction in the tumor environment and immune escape was demonstrated when the disruption of this interaction by antagonistic antibodies led to tumor regression in many animal models [7] and was further confirmed by successful clinical trials with PD-1/PD-L1 antagonistic antibodies [47].